Old Web
English
Sign In
Acemap
>
authorDetail
>
Chrisoph Losem
Chrisoph Losem
Bendamustine
Immunology
Rituximab
Medicine
Mantle cell lymphoma
2
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Subanalysis of the StiL NHL 1–2003 Study: Achievement of Complete Response with Bendamustine-Rituximab (B-R) and CHOP-R in the First-Line Treatment of Indolent and Mantle Cell Lymphomas Results in Superior Survival Compared to Partial Response.
2012
Blood
Mathias Rummel
N. Niederle
Georg Maschmeyer
G.‐Andre Banat
Ulrich von Grünhagen
Chrisoph Losem
Dorothea Kofahl-Krause
Gerhard Heil
Manfred Welslau
Christina Balser
Ulrich Kaiser
Eckhart Weidmann
Heinz A. Duerk
Harald Ballo
Martina Stauch
F Roller
Juergen Barth
Axel Hinke
Alexander Burchardt
Wolfram Brugger
Show All
Source
Cite
Save
Citations (2)
No Elevated Rates of Treatment-Related Myelodysplastic Syndromes and Second Solid Tumors Following Therapy with Bendamustine Compared with Other Anti-Lymphoma Regimes for Low-Grade Non-Hodgkin9s Lymphoma
2010
Blood
Mathias Rummel
A Tenzer
Norbert Niederle
Chrisoph Losem
Christina Balser
Harald-E. Balló
Manfred Welslau
Ulrich von Grünhagen
Wolfram Brugger
Georg Maschmeyer
Axel Matzdorff
Arnold Ganser
Eckhart Weidmann
Gerhard Heil
Axel Hinke
Jürgen Barth
Show All
Source
Cite
Save
Citations (5)
1